Name | Company Name | Weight % | Market Value | Market Cap | Yearly Gain | Overall Rating |
|---|---|---|---|---|---|---|
| Exxon Mobil | 3.53% | $1.36B | $626.04B | 37.15% | 74 Outperform | |
| Johnson & Johnson | 3.29% | $1.27B | $586.69B | 55.91% | 78 Outperform | |
| JPMorgan Chase | 2.64% | $1.02B | $823.62B | 9.38% | 72 Outperform | |
| AbbVie | 2.62% | $1.01B | $409.15B | 20.03% | 66 Neutral | |
| Apple | 2.53% | $973.61M | $3.76T | 4.57% | 79 Outperform | |
| Philip Morris | 2.52% | $970.98M | $291.89B | 24.62% | 61 Neutral | |
| Procter & Gamble | 2.49% | $959.85M | $372.00B | -1.73% | 69 Neutral | |
| Microsoft | 2.30% | $886.52M | $2.98T | -1.74% | 79 Outperform | |
| Home Depot | 2.23% | $858.22M | $389.29B | -4.50% | 66 Neutral | |
| Merck & Company | 2.15% | $828.81M | $301.34B | 46.26% | 80 Outperform |